Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Certara, Inc. - Common Stock
(NQ:
CERT
)
10.00
-0.11 (-1.09%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Certara, Inc. - Common Stock
< Previous
1
2
3
Next >
Healthcare AI Exits Pilot Phase, Enters Production Deployment
December 12, 2025
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
Certara Appoints Jon Resnick as Chief Executive Officer
December 11, 2025
From
Certara
Via
GlobeNewswire
Certara Reports Third Quarter 2025 Financial Results
November 06, 2025
Updates Full Year 2025 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara Automates Scientific Workflows with Phoenix® Cloud
November 04, 2025
New cloud capabilities cut time to create Tables, Figures, and Listings by 50%
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
October 31, 2025
From
Certara
Via
GlobeNewswire
Certara Expands Biosimulation Market with AI-Driven QSP Platform
October 30, 2025
Certara IQ™ integrates AI and biosimulation to accelerate R&D productivity, reduce risk, and deepen understanding of novel and complex therapies
From
Certara
Via
GlobeNewswire
Certara Scientists are Among the Topmost Cited Biopharma Researchers
October 20, 2025
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025
From
Certara
Via
GlobeNewswire
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
October 10, 2025
From
Certara
Via
GlobeNewswire
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
September 04, 2025
Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurements
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
September 02, 2025
From
Certara
Via
GlobeNewswire
Certara Reports Second Quarter 2025 Financial Results
August 06, 2025
Reiterates Full Year 2025 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
August 04, 2025
From
Certara
Via
GlobeNewswire
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
July 31, 2025
Strengthening technology innovation and leadership of the Certara AI/ML-enabled biosimulation platform used to speed time to market in drug discovery and development
From
Certara
Via
GlobeNewswire
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
July 09, 2025
From
Certara
Via
GlobeNewswire
Certara Announces Expansion of Clinical Technology Collaboration with Merck
July 08, 2025
Expands use of the Certara Pinnacle 21® (P21) enterprise software platform to optimize clinical data flows for speed and quality
From
Certara
Via
GlobeNewswire
Certara Reports First Quarter 2025 Financial Results
May 05, 2025
Reiterates Full Year 2025 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
April 29, 2025
From
Certara
Via
GlobeNewswire
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
April 14, 2025
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies
From
Certara
Via
GlobeNewswire
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
April 14, 2025
From
Certara
Via
GlobeNewswire
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
April 01, 2025
Updates strengthen Certara’s position as a leader of PBPK modeling in drug development to advance regulatory decision-making
From
Certara
Via
GlobeNewswire
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
March 05, 2025
McKemey joins Certara to accelerate growth of its strategic drug development solutions
From
Certara
Via
GlobeNewswire
Certara Reports Fourth Quarter 2024 Financial Results
February 26, 2025
Issues Full Year 2025 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
January 29, 2025
From
Certara
Via
GlobeNewswire
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025
From
Certara
Via
GlobeNewswire
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 02, 2025
From
Certara
Via
GlobeNewswire
Certara Showcases 2024 Research Wins With Over 100 Papers Published
December 02, 2024
The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list
From
Certara
Via
GlobeNewswire
Certara Reports Third Quarter 2024 Financial Results
November 06, 2024
Updates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Participate in the Stephens Annual Investment Conference
October 28, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024
From
Certara
Via
GlobeNewswire
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From
MaxCyte, Inc
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
